Novel Tyrosine Kinase Inhibitor Therapy (NTKI) Prior to Allogeneic Stem Cell Transplantation (ASCT) in Patients with Chronic Myeloid Leukemia (CML): No Evidence for Increased Transplant-Related Toxicity.
Year: 2006
Type: article
Study design: Observational Study
Source: Blood
Authors: Elias Jabbour, Jorge Cortes, Hagop Kantarjian, Sergio Giralt, Francis Giles, Borje S. Andersson, Richard Champlin, Marcos de Lima
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2550069897